Mepolizumab as the first targeted treatment for eosinophilic granulomatosis with polyangiitis: a review of current evidence and potential place in therapy

Faverio P, Bonaiti G, Bini F, Vaghi A, Pesci A

Therapeutics and Clinical Risk Management 2018, 14:2385-2396

Published Date: 7 December 2018